Story thread · 3 reports / 2 sources
United Therapeutics bid to expand nebulized Tyvaso label gets FDA review
seekingalpha.com · 12d
First report: United Therapeutics highlights new data supporting two FDA filings — seekingalpha.com, 15d
The coverage
- Capricor Therapeutics shares rise 2.5% following August FDA update
finance.yahoo.com · 13d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.